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Abstract
Cells are able to navigate environments, communicate, and build complex patterns by initiating 
gene expression in response to specific signals. Engineers need to harness this capability to 
program cells to perform tasks or build chemicals and materials that match the complexity seen in 
nature. This review describes new tools that aid the construction of genetic circuits. We show how 
circuit dynamics can be influenced by the choice of regulators and changed with expression 
“tuning knobs.” We collate the failure modes encountered when assembling circuits, quantify their 
impact on performance, and review mitigation efforts. Finally, we discuss the constraints that arise 
from operating within a living cell. Collectively, better tools, well-characterized parts, and a 
comprehensive understanding of how to compose circuits are leading to a breakthrough in the 
ability to program living cells for advanced applications, from living therapeutics to the atomic 
manufacturing of functional materials.
Introduction
The ability to perform computation in a living cell will revolutionize biotechnology by 
improving existing products and enabling new applications. In the short term, the production 
of bio-based chemicals can be improved by timing gene expression at different stages of 
fermentation, or turning on an enzyme only under particular conditions (e.g., low 
oxygen)1–6. As circuits become more advanced, entire algorithms from control theory could 
be applied to improve biochemical production (Fig. 1a)7–16. Synthetic regulation is also an 
important tool for the discovery of natural products, including pharmaceuticals, insecticides, 
and entirely new classes of chemicals. Accessing these products may require the coordinated 
expression of genes identified in sequence databases, intractable organisms, or “silent” gene 
clusters17–22. Moving outside of the fermenter, living cells could be programmed to serve as 
therapeutic agents that correct genetic disease (Fig. 1b) or colonize niches in the human 
microbiome to perform a therapeutic function (Fig. 1c)23–35. Longer-term capabilities 
include “smart plants” that sense and adapt to environmental challenges (Fig. 1d) and 
bacteria that organize to weave functional materials with nanoscale features36–42.
Despite its potential, genetic circuit design remains one of the most challenging aspects of 
genetic engineering43. The earlier fields of protein and metabolic engineering have yielded 
tools to optimize enzymes and fluxes through a metabolic network. These tools include 
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computational methods that can predict the impact of an amino acid substitution on protein 
thermostability44 or the distribution of flux through modified metabolic networks45. Biotech 
companies often have research groups dedicated to protein and metabolic engineering that 
have specialized training in these tools. However, industrial groups dedicated to building 
synthetic regulation are rare and even simple tasks, like building a switch or inducible 
system, tend to be one-off projects performed by a non-specialist.
Several features of genetic circuits make them challenging to work with, as compared with 
other areas of genetic engineering. First, circuits require the precise balancing of their 
component regulators to generate the proper response46,47. Computational tools and part 
libraries that enable the tuning of expression levels have only been developed recently48–51. 
Before this, only course-grained control was achievable with small sets of parts46,47,52. 
Second, many circuits are difficult to screen in directed evolution experiments for correct 
performance. Digital logic has clear on and off states that can form the basis for a 
screen12,53–59. However, screening for dynamic circuits, such as oscillators, is significantly 
more complex60 and it is hard to imagine how screens would be established for more 
sophisticated functions, like a PID controller with proscribed response properties. Third, 
there are few tools to measure circuit performance. Typically, a fluorescent reporter is used 
to measure the output, but fluorescence detection requires artificially high expression levels 
and fluorescent protein degradation rates can limit the ability to measure dynamics. Fourth, 
synthetic circuits are very sensitive to environment, growth conditions, and genetic context 
in ways that are poorly understood61. Finally, the process of building a large genetic circuit 
requires the assembly of many DNA parts and this process has been both technically 
challenging (until recently) and fraught with its own sources of errors58,62–67.
The purpose of this review is to serve as a guide to designing a prokaryotic transcriptional 
circuit, where both the inputs and outputs are promoters53,55,68–71. Transcriptional circuits 
maintain a common signal carrier, which simplifies the connection of circuits to build up 
sophisticated operations72. Post-transcriptional circuits, including those based on protein and 
RNA interactions, are covered in other excellent reviews73–75. Although the majority of this 
guide is dedicated to bacterial circuits, many of the principles, albeit not the details, are 
relevant for eukaryotes, including human cells and plants76,77.
I. Genetic circuit design based on different regulator classes
Transcriptional circuits operate by affecting the flow of RNA polymerase (RNAP) on DNA. 
There are a number of molecules that impact this flux that have been used as the basis for 
building synthetic circuits (Fig. 2). For example, DNA-binding proteins can recruit or block 
RNAP to increase or decrease the flux, respectively. Analogously, the new CRISPRi system 
uses Cas9 protein to bind to the DNA and alter transcription78,79. RNAP flux can also be 
altered with invertases that change the orientation of promoters, terminators, or gene 
sequences. Additionally, RNA translational repressors, such as RNA-IN/OUT, can be 
converted to control RNAP flux80,81. In this section, we describe recent advances in these 
methods and analyze the impact that each regulator has on circuit response.
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DNA-binding Proteins
Many families of proteins can bind to specific DNA sequences (operators). The simplest 
way to use these proteins as regulators is to design promoters with operators that block the 
binding or progression of RNAP. Such repressors have been built out of zinc finger proteins 
(ZFPs)82, transcription activator-like effectors (TALEs)83,84, TetR homologues71, phage 
repressors85,86, and LacI homologues87. A core set of ~3 repressors were re-used in many of 
the first synthetic circuits (CI, TetR, LacI)47,53,88–91. However, recently there have been 
efforts to expand the number of DNA-binding proteins that are available for circuit 
design54,92–99. Expanding protein libraries can be challenging because each repressor has to 
be orthogonal; i.e., only interact with their operator and not the others in the set. Because of 
their simple function, repressors are relatively easy to move between species, including to 
eukaryotes92–97. DNA-binding proteins can also function as activators that increase the flux 
of RNAP on DNA. Activators either recruit host RNAP to a promoter or are alternative 
RNAPs that transcribe genes directly. Recent efforts have increased the number of such 
proteins that are available for constructing circuits54,98–100.
Many logic gates have been constructed with DNA binding proteins that recruit or block 
RNAP71,101–109. For example, NOT and NOR gates have been built with inducible 
promoters that drive expression of repressors (Fig. 2a)71,11047,53,88. Additional 
transcriptional logic has been achieved with regulators that bind directly to the proteins to 
either inhibit or enhance their function. For example, AND gates have been built with 
activators that require chaperones (Fig. 2b)55,101 and with artificially split proteins111. 
Similarly, NAND gates can be built with proteins that block the activity of an activator, such 
as anti-σ factors, which inhibit σ factors100.
Of the regulators described in this review, DNA-binding proteins are the only class (so far) 
that has been used to build dynamic circuits. This includes pulse generators112, bistable 
switches47,53,113, counters69, feedback loops, and oscillators that have different periods and 
amplitudes70,88,114–116. Analog computing modules have also been built with DNA binding 
proteins, which highlights the diverse signal processing capabilities of these 
regulators55,71,101,103,110.
Invertases
Invertases are site-specific recombinase proteins that facilitate the inversion of DNA 
segments between binding sites117. All invertases mediate “cut-and-paste” recombination, 
during which DNA is looped, cleaved and re-ligated118. Two types of invertases have been 
used to build genetic circuits. The first are tyrosine recombinases, such as Cre, Flp, and 
FimBE, which require host-specific factors69,119–121. These recombinases can be reversible 
and flip the DNA in both directions, or irreversible and only flip in a single direction. The 
second class of invertases are serine integrases, which catalyze unidirectional reactions that 
rely on double stranded breaks to invert DNA. Serine integrases typically do not require host 
factors and often have cognate excisionases that can be expressed independently to return 
the DNA to its original orientation.
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Invertases have been used to build switches119, memory circuits120,121, counters69, and logic 
gates122,123. These proteins are ideal for memory storage, because they flip DNA 
permanently and once flipped they do not require the continuous input of materials or 
energy to maintain their new orientation. In invertase logic gates, these discrete physical 
states of the DNA can correspond to on and off states (0 and 1). However, using invertases 
can be challenging because their reactions are slow (requiring 2–6 hours) and can generate 
mixed populations when targeting a multicopy plasmid121. Reversible invertases can also 
generate mixed populations, however this limitation was overcome recently by using a 
serine integrase to flip DNA in one direction and an integrase/exisionase pair to return it to 
the original state124.
All two-input gates, including AND and NOR logic, have been constructed using orthogonal 
serine integrases (Fig. 2c and 2d)122,123. The gates are organized such that two input 
promoters express a pair of orthogonal recombinases, which change RNAP flux by inverting 
unidirectional terminators, promoters, or entire genes. These gates are based on 
unidirectional serine integrases without excisionases, therefore they operate as memory 
circuits that remember exposure to two input signals. Once flipped, the circuits cannot be 
returned to their original state, therefore the gates do not distinguish the order they were 
exposed to the inputs or even if they occurred at the same time.
CRISPRi
CRISPR (Clustered Regularly Spaced Short Palindromic Repeat) arrays function as a 
bacterial “immune system” that targets specific DNA sequence motifs for degradation125. 
CRISPR systems utilize a Cas nuclease and guide RNA to introduce double strand breaks to 
specific DNA sequences126. Mutant Cas proteins (dCas979, Cas9N-127) that do not have 
nuclease activity have been developed and used as transcription factors that knock down 
gene expression by forming a DNA bubble that interferes with RNAP activity78,79. CRISPR 
can also activate transcription via fusion of an RNAP recruiting domain to catalytically 
inactive Cas978,127–131. Considering the needs of synthetic circuits, one advantage of 
CRISPRi is the designability of the RNA-DNA complex. It is possible to imagine creating a 
very large set of orthogonal guide sequences that target different promoters. This set would 
enable the construction of large genetic circuits, however it would need to be experimentally 
screened because predicting guide RNA orthogonality is complicated132–135.
CRISPRi is still relatively new and NOT gates are the most complex circuits built to date79. 
The NOT gates induce sgRNA and dCas9 expression simultaneously to repress transcription 
at an output promoter. In theory, a NOR gate could be created by introducing a second 
sgRNA that targets the same output promoter (Fig. 2e). In general, CRISPRi circuits will 
probably resemble DNA binding protein circuits. However, unlike the repressor based NOR 
gate (Fig. 2a), the CRISPRi NOR gate will need to have the sgRNAs expressed from 
separate input promoters because 5′ RNA extensions can reduce or eliminate activity (Fig. 
2e)134. Circuits based on CRISPRi are expected to operate on similar timescales to protein-
based circuits because of the stability of the regulatory dCas9/sgRNA/DNA duplex79.
A current challenge in implementing CRISPRi circuits is toxicity, which is difficult to 
control. Toxicity is most likely the result of Cas9 binding to the host genome at PAM 
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sequences (NGG), forming bubbles that deleteriously impact host gene expression136,137. 
Another consideration for building CRISPRi circuits is retroactivity138, which could arise 
from using Cas9 as a shared resource (Section III). One way to circumvent retroactivity 
would be to express multiple orthogonal Cas9 homologues132,139.
Adapted RNA-IN / RNA-OUT
The RNA-IN/OUT system from E. coli represses translation of a target protein when a short 
noncoding RNA (RNA-OUT) is expressed. In the natural system, RNA-OUT binds to a 
specific sequence at the 5′ end of an mRNA (RNA-IN) to occlude ribosome binding and 
increase mRNA degradation140–142. Arkin and co-workers retooled this system to repress 
transcription, instead of translation, using a transcriptional adaptor from the tna operon80. 
The tna regulatory element is composed of a ribosome binding site (RBS), the coding 
sequence for a short peptide called tnaC, a Rho binding site and an RNAP pause site that 
facilitates Rho-mediated transcription termination. Translation of tnaC causes ribosomal 
stalling, which blocks Rho-factor binding and allows RNAP to transcribe genes downstream 
of tnaC. However, when translation of tnaC is prohibited, Rho binds the growing mRNA 
and knocks off RNAP thereby inhibiting transcription elongation. RNA-IN/OUT RNAs 
regulate transcription elongation by altering translation of tnaC. Like CRISPRi, the adapted 
RNA-IN/OUT system could be used to generate a large set of orthogonal regulators because 
it is based on designable RNA-RNA interactions. To date, more than 150 different families 
of at least seven orthogonal RNA-IN/OUT mutants have been designed using an RNA-
IN/OUT model and all of the mutants tested experimentally have been functional and 
orthogonal81.
Adapted RNA-IN/OUT has been used to build two-, three-, and four-input NOR gates (Fig. 
2f)80. In these systems, orthogonal RNA-IN variants were connected such that expression of 
any cognate RNA-OUT represses transcription of the output gene. Additional layers of 
regulation could be engineered into the adapted RNA-IN/OUT system with ligand-
responsive aptamers that regulate RNA-OUT activity143 or tRNAs that control ribosomal 
pausing in tnaC144. A challenge in building larger RNA-IN/OUT circuits is that each 
transcriptional regulator requires the same tna regulatory element (~290bp). The re-use of 
this part in multiple circuits could lead to homologous recombination (Section III). 
Engineering TnaC to reduce the length of the repeated sequence80 or using homologs from 
other organisms and alternative Rho binding sites could potentially attenuate recombination.
II. Selecting Parts to Tune the Circuit Response
Genetic circuits need to be tuned to meet the specifications required for a particular 
application. For example, a large dynamic range may be required to strongly activate a 
pathway. Similarly, low off states are desirable when expressing toxic proteins145. When the 
first synthetic circuits were built, there were few options available for tuning circuits and 
only course-grained changes were possible46,47. New libraries of well-characterized parts 
and computational tools have made it easier to design and tune genetic circuits. Moreover, 
new classes of insulators improve the reliability of these parts when they are placed in the 
local genetic context of a circuit. Additional biochemical interactions, such as small RNA 
(sRNA), have been incorporated into circuits in order to provide additional tuning knobs. In 
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a prior review, we detailed advances in part design and tools to obtain reliable expression 
levels146. Here, we show how the selection or modification of different parts impacts the 
response of a circuit.
Two circuits are used as model systems to demonstrate the effects of various tuning knobs. 
The first, a NOT gate, represents a simple logic operation (Fig. 3a)46,53. Logic gates are 
often characterized by their response function, which captures how the steady-state output 
changes as a function of input. The shape of this function is defined by: 1. the ON and OFF 
states, which define the circuit’s dynamic range, 2. the amount of input required to reach the 
half-maximum output (also referred to as the threshold), and 3. cooperativity of the 
switch147,148. An oscillator was selected as an example of a dynamic circuit (Fig. 3h). These 
types of circuits can be very difficult to tune because they need to be balanced in a narrow 
region of parameter space in order to function properly90,149,150. For an oscillator, tuning 
will affect the period, amplitude, and shape of the oscillations. Tuning can also force the 
system out of the oscillating parameter space and cause the circuit to fail90.
The response function of a digital logic gate can be shifted up or down by changing 
promoter strengths (Fig. 3b)151, ribosome binding sites (RBS), or the proteins’ degradation 
rates (Fig. 3c)152. Promoter strength can be altered with mutations in the promoter 
sequence153 or by selecting new promoters from a characterized library49,154. Increased 
degradation can be achieved with protease tags or N-terminal degrons152. Circuit 
components are often distributed between multiple plasmids at different copy numbers in 
order to synthesize each component at the necessary level. However, when entire circuits are 
expressed on one plasmid, copy number can be shifted to simultaneously alter the circuit’s 
dynamic range and threshold (Fig. 3d). Different origins of replication can generate complex 
and poorly understood effects on expression, for example, by changing localization and 
supercoiling. This can be minimized by using plasmid systems where the copy number can 
be controlled without changing the origin155.
The threshold of the gate can be changed via several methods. Selecting a stronger or 
weaker RBS, adding multiple operators, or changing operator positions within the 
repressible promoter can change the threshold (Fig. 3e)59,71,156,157. The threshold of a gate 
becomes steeper and more switch-like when small changes in the input have a large effect 
on the output158. This phenomenon, known as ultrasensitivity, can be important for 
controlling actuators where intermediate levels of expression are undesirable158. It can also 
make connecting gates easier by decreasing the range of input needed from an upstream 
circuit to span the induction threshold. One way to make a gate ultrasensitive is to change 
the cooperativity of repressor binding to the promoter or to introduce DNA looping159,160. 
Another approach is to express a sequestering molecule that binds a circuit component and 
prevents it from functioning. Sequestration has been achieved using sRNAs that bind to 
mRNA161,162 (Fig. 3f), proteins that bind to transcription factors113,163,164, and decoy DNA 
operators that titrate the transcription factor away from the output promoter165 (Fig. 3g).
In an oscillator, parts that impact the rate of gene expression change the amplitude of the 
response and can shift the period (Fig. 3i,l). Rapid protein degradation is critical for dynamic 
circuits to function correctly. If proteins are slow to degrade, then the circuit may slow down 
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or stop functioning altogether (Fig. 3j)166. Protease tags can be used to decrease the 
degradation rate from several hours to ~20 minutes, which will increase the rate at which a 
gate switches15270,89,112. Cooperativity is critical for obtaining robust oscillators because it 
increases the region of phase space that produces oscillations159. Therefore, sequestration 
approaches (e.g., sRNA or dummy operators) are predicted to have a large impact on the 
period and amplitude of oscillations (Fig. 3m–n)167.
III. Common Failure Modes from Connecting Circuits
Gates can be combined to build larger circuits that implement more sophisticated 
computational operations. To connect transcriptional gate, the output promoter of one circuit 
is used as the input promoter to the next. This method applies for all transcriptional circuits, 
including digital, analog and dynamic circuits or a combination of types. To connect 
circuits, they have to broken up into their component parts and then combined in a particular 
order (Fig. 4a). Reorganizing the parts places them in new local contexts that are different 
from those where they were characterized. This can be problematic because circuit 
components can behave differently in new genetic contexts and small circuits may have 
identical component parts (e.g., terminators) that interfere with each other in the larger 
circuit. In this section, we discuss failure modes that can arise when building larger circuits, 
show the impact that each failure has on circuit function, and discuss engineering 
approaches to mitigate these problems.
When connecting circuits, a common problem is that the upstream circuit’s output does not 
span the dynamic range required to stimulate next circuit in series (Fig. 4b). In digital logic, 
this ‘mismatch’ manifests as either a decrease in the dynamic range of the complete circuit 
or a loss of function. Connectivity mismatches can be corrected by selecting parts that shift 
the thresholds of individual gates. For example, RBSs can be mutated to force the threshold 
of a gate to fall within the dynamic range produced from an upstream circuit46,102. 
‘Mismatches’ in an oscillator can dampen oscillations or force the system outside the 
functional parameter space (Fig. 4b). Mathematical models could be used to streamline 
circuit design by predicting the functional parameter space and selecting appropriate RBSs 
and promoters to achieve the required expression levels48,68,157.
Genetic parts are often context dependent, meaning their functions change when the DNA 
sequences on either side of the part are altered168,169. Context dependencies complicate part 
substitutions because part characterizations are often carried out in isolation and their 
activity in a new context may not match the measured strength. For example, promoters are 
that are defined as DNA sequences <50 bp may behave differently in new contexts because 
the α-domain of E. coli RNAP can contact the DNA ~100 bp upstream of the transcription 
start site153. In a digital circuit, reducing promoter efficiency attenuates the response of 
individual gates and reduces the output of the complete circuit (Fig. 4c). Promoter 
attenuation can increase the amplitude of an oscillator and elongate the period, by reducing 
repressor expression. Insulator sequences can relieve some compositional context effects by 
standardizing the DNA sequences flanking promoters169,170.
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Context effects can also occur when promoters are fused to different RBSs. Promoters are 
sensitive to the DNA sequences near the transcription start site because that region can alter 
promoter melting and polymerase escape frequency154. Transcription start sites can also 
fluctuate based on the local sequence context171,172, which can impact RBS strength by 
altering the length of the 5′-UTR and changing mRNA secondary structure. Tandem 
promoters can generate especially long 5′-UTRs that exacerbate this effect by base pairing 
with the RBS or sequences in the open reading frame173–175. Circuits can fail completely 
when mutations in the 5′-UTRs cause hairpins completely occlude the RBSs and prohibit 
translation (Fig. 4d). To solve these problems, the 5′-UTR can be cleaved with ribozymes or 
CRISPR processing to standardize RBS accessibility170,176. Catalytic insulator elements 
serve dual functions by standardizing both the 5′ end of mRNA and the promoter region 
downstream of the transcription start site. RBSs can be further insulated from the local 
context using bicistronic designs, which prime the mRNA for translation with an upstream 
RBS that keeps the mRNA unfolded49.
Transcriptional read-through can be a problem in genetic circuits with monocistronic 
designs, where every gene has its own promoter and terminator. These designs require 
strong terminators to insulate against read-through from neighboring promoters. Failure to 
fully insulate each cistron can link the expression of genes that are supposed to be regulated 
independently (Fig. 4e) and can contribute to the leaky expression of uninduced genes. 
Strong, tandem terminators can be placed on either side of each gene to ensure isolated 
expression of individual operons177. Large libraries of rho-independent terminators were 
recently built and characterized to enable the construction of large circuits that are robust to 
read-through and homologous recombination (described below)50,177.
DNA sequences are information rich, therefore connecting two parts can create a new 
functional sequence at the junction178. New regulatory elements, such as promoters or 
terminators, can be generated at a part junction if the combination creates a sequence of 
DNA that resembles a regulatory element. For large circuits, many parts have to be 
combined in a new order and unexpected parts that interfere with gene expression can be 
generated (Fig. 4f). One way to scan for unintended functional sequences is to use computer 
algorithms that search for various regulatory elements48,177,179–185.
Crosstalk, which occurs when regulators interact with each other’s targets, can change the 
topology of a circuit and can lead to errors in the desired operation55. For example, crosstalk 
between a repressor and non-cognate promoter can inappropriately decrease expression of a 
gene and cause a circuit to fail (Fig. 4g). Avoiding crosstalk requires that parts be screened 
for orthogonality via combinatorial experiments that test every combination of promoter and 
regulatory element71,81,83,98,100,186.
Many of the circuits built to date re-use the same regulatory parts, which can lead to 
homologous recombination. Homologous recombination deletes DNA between repeated 
sequences and can result in the loss of circuit components and circuit failure (Fig. 4h)177. In 
general, the rate of recombination increases with circuit toxicity187 and homolgous DNA 
length, with the threshold occurring between 20–30bp188. Homologous recombination can 
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be avoided with large libraries of parts with redundant functions that have enough sequence 
diversity to avoid recombination177,189.
IV. Interactions between Synthetic Circuits and the Host Organism
Genetic circuits are based on biochemical interactions within living cells. Most circuits use 
host resources to function, including transcription/translation machinery (e.g., ribosomes and 
RNAP), DNA replication equipment, and metabolites (e.g., amino acids). The availability of 
these resources and the details of the intracellular environment change significantly in 
different strain backgrounds, environmental conditions, media, growth rate, and cell density. 
When the first synthetic circuits were built, they were fragile and it was unclear why they 
would only work in specific conditions20,21. Now, there is a more precise understanding of 
the ways in which circuits break due to interactions with the host61. A better understanding 
these failure modes are and the methods natural systems use to overcome them will lead to 
new design rules for composing synthetic circuits.
A common observation is that some synthetic regulators can cause growth defects. Yet it 
remains unclear why certain regulators can be expressed at high levels with no noticeable 
impact whereas others in the same class are very toxic. This was evident in analyzing large 
libraries of TetR and σ factor homologues sourced from diverse organisms and transferred 
into E. coli71,100. Expression of some of regulators slowed E. coli growth, but the origin of 
this effect is unclear as it does not correlate with the number of predicted binding sites in the 
genome or off-target gene expression measured using RNA-seq. T7 RNAP is another part 
that can be very toxic when combined with a strong T7 promoter102. It is also unclear how 
this toxicity arises, but it could be due to the difficulty terminating T7 RNAP, which could 
cause circular transcription on a plasmid or expose mRNA by decoupling RNAP and 
ribosome progression. Circuits based on protein-protein interactions can also exhibit toxicity 
when the proteins bind to off-target partners. We observed this with anti-σ factors, which 
appear to bind and titrate native σ factors100. Small RNA with RBS-like sequences can also 
cause toxicity by titrate ribosomes, increasing expression variability, and reducing growth 
(Fig. 5a)145. Larger circuits are particularly sensitive to the toxicity that can arise from 
individual regulators because their effects are compounded when they are expressed 
together190.
Circuits can also decrease growth rate by monopolizing host resources and slowing essential 
protein/RNA production (Fig. 5a)191. A small reduction in the growth rate can be a problem 
when using a circuit for industrial applications that rely on high product yields. A decrease 
in growth rate can reduce the dilution rate of circuit components and lead to unintended 
build up of proteins or RNA that can cause a circuit to fail. In fact, circuits can appear to 
function better when growth is impeded because slow dilution increases the observed 
concentration of transcription factors and reporters. Slow growth can also put pressure on 
the host organism to evolve away the burdensome circuit, either via homologous 
recombination, point mutations/deletions, or copy number reduction.
Circuits can diverge from their expected behavior when they use a limited resource that is 
shared with other cellular processes. Overburdening resources causes queuing, which results 
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in a delay or reduction in circuit activity192. For example, when σ factors are overexpressed, 
they can occupy the entire pool of free core RNAP. When this happens, sigma factors must 
compete to bind to the core, which indirectly couples their activity and can disrupt host 
processes193. Native σ factors are able to avoid queuing by pulsing their expression such that 
they alternate the usage of core RNAP over time194. A similar coupling effect has been 
observed when the ClpXP protease is shared by regulators that have been modified to 
contain C-terminal tags for fast degradation. If too many proteins are targeted for 
degradation, the enzymatic machinery can become overwhelmed and force substrates to wait 
for processing166. The rapid degradation of regulators is important for dynamic circuits, 
such as oscillators, which will fail if the regulatory proteins accumulate (Fig. 5b).
Retroactivity can also interfere with circuit activity. Retroactivity is defined as the influence 
that a downstream genetic element can have on an upstream one and it describes the changes 
in circuit behavior that result from connecting new downstream modules to a circuit138. 
Downstream modules may affect the performance of upstream circuits by titrating regulators 
away from the original circuit. For example, connecting a second output to a NOT gate may 
cause retroactivity by titrating the repressor away from the original output promoter (Fig. 
5c). Retroactivity will impact the NOT gate’s dynamics by increasing the time it takes to 
build up an adequate amount of protein to repress promoter activity195. Retroactivity that 
delays a circuit’s response to input stimulation can be alleviated by increasing expression of 
the problematic circuit component; however, increasing expression can lead to other trade-
offs, including toxicity.
Strain variation can affect circuit performance in different ways. Differences in growth rate, 
ribosome concentration, and induction lag time have been identified as the main contributors 
to strain dependent variations in circuit performance196. In recent studies, these phenotypes 
have been correlated with specific genes by studying growth and circuit performance across 
single gene knockouts (Fig. 5d)196197. Media and growth conditions can also impact circuit 
performance by altering promoter activity, protein stability, and regulator dilution198,199. 
These effects can be so severe that switching from LB to minimal media can cause circuits 
to fail (Fig. 5e)2.
One approach to reduce strain- and media-based variation is to use reference standards to 
report circuit performance. To this end, the Relative Expression Unit (REU) was introduced 
as a standard for reporting promoter measurements2,200. REUs report the promoter activity 
by normalizing measurements to a constitutive promoter standard in a strain that is treated 
identically and measured simultaneously. REU measurements have yielded reliable, 
reproducible data when compared across labs, strains, and media, which is important for 
transcriptional circuits that use promoters as inputs and outputs. In the future, this will 
facilitate the computer-aided design of large circuits.
Conclusions
The first circuits were built by repurposing a small number of regulators and genetic parts 
from other areas of genetic engineering. After early success47,88, these parts were put 
together in different combinations to explore the range of circuit functions that could be 
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performed in the cell. We are now in a phase where there are >100 new 
regulators55,71,78–80,82,83,101,146,180 that are orthogonal and could theoretically be used to 
build synthetic regulatory networks at the scale of natural networks in bacteria201.
There are several key advances that have to happen before we can build and debug genetic 
circuits this large. First, computational tools have to be developed to aid the design process. 
These programs need to be able to simulate the dynamics of a circuit and convert the designs 
into a linear assembly of genetic parts68,202–205. Insulating DNA sequences will be critical 
in future circuits because the majority of parts will be in new contexts206,207. Second, new 
approaches to whole cell omics measurements have to be integrated into the debugging 
cycle. Currently, there is an over-reliance on fluorescent proteins as the output of circuits. 
However, transcriptomics is now sufficiently inexpensive such that it could be used to infer 
polymerase flux on many of the parts internal to a circuit208. Other single molecule 
approaches, such as ribosome and RNAP mapping, will become powerful when the 
experiments become more routine209,210. Third, new approaches need to be developed that 
can rapidly test circuits under conditions that are difficult to control in the cell. Circuits are 
sensitive to parameters like the number of ribosomes, RNAP, redox, temperature, and ATP 
all of which change in different cell types and conditions. However, these are difficult to 
measure in the cell without broadly impacting the host. To this end, the development of in 
vitro cell-free methods to debug circuits will be valuable for designing circuits that are 
robust to these changes211,211–220.
New biochemistries, tuning knobs, and troubleshooting methods are now converging for the 
sophisticated design and construction of genetic circuits. In these circuits, different classes 
of regulators can be used in a single circuit to fulfill specialized functions. In this vision, 
each regulator has found a niche within the larger circuit that exploits their strengths. For 
example, digital circuits can be used to integrate sensors and respond to a particular set of 
conditions, whereas analog circuitry can perform arithmetic function functions with a small 
number of regulators103. Integrases can store memory or cause an irreversible commitment. 
CRISPRi can regulate essentially any gene in the genome. A vision of this marriage is 
shown in Figure 6, which is an example of a commensal bacterium that has been engineered 
to produce a pharmaceutical while colonizing the gut. In it, repressor-based logic gates 
respond dynamically to environmental states and invertases record these observations. 
Analog circuits can be used to calculate a dosage rate and, if surpassed, CRISPRi knocks 
down specific host genes to arrest growth and avoid overmedication. Collectively, these new 
circuits and the tools and knowledge to connect and debug them will enable a new era of 
cellular programming and the applications that come with this capability.
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Figure 1. Potential uses of synthetic genetic circuits
Here, we present several hypothetical uses of circuits in different application areas. (a) In 
industrial applications, most synthetic metabolic pathways are overexpressed at all times or 
are under simple inducible control. This could be improved by incorporating timing, 
feedback of metabolic intermediates, or dynamic control. Here, we show a circuit that is 
controlling the production of a diesel fuel alternative (bisobolane221) by regulating the 
accumulation of a toxic intermediate (HMG-CoA) by sensing sugar, which induces 
oscillations in the production of HMGR. This type of oscillatory control occurs in natural 
metabolic networks222. (b) Gene therapy circuits could be built based on CRISPRi 
technology by detecting SNPs and integrating this information with tissue-specific sensors. 
As a hypothetical example, we show a circuit that could detect two SNPs associated with 
colon cancer susceptibility (rs4444235 and rs9929218)223 and this is integrated with a 
promoter that is specific to colon cells (pAMUC2) to control the expression of misregulated 
genes (DLGAP5, NO3, and DDX28). (c) Bacteria could be programmed to colonize human 
microbiota and implement a therapeutic response. An example is envisioned where a 
commensal bacterium is used to stabilize pH to treat gastoesophageal acid reflux (GERD). A 
bacterium that is naturally commensal with the stomach could be programmed to maintain 
the pH using a circuit that enables set point control via a PI controller9,224 whose output is 
proton pump inhibitors (PPIs). The circuit also restricts acid regulation to the stomach by 
terminating the bacterium via an irreversible switch if it leaves this organ225. (d) Genetic 
circuits could also be used to build “smart plants” that are able to sense environmental 
stimuli and implement a response. Currently, traits are produced all the time whether or not 
they are needed by the plant. Here, we envision a circuit that would operate in the 
chloroplast integrate sensors for drought (pSpark), temperature (pCBF), and plant maturity 
(pSAG12) to control multiple traits. This could reduce the amount of recombinant protein 
that is produced and enters the food supply without reducing the effectiveness of the trait.
Brophy and Voigt Page 22
Nat Methods. Author manuscript; available in PMC 2014 November 13.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2. Logic gates built based on different regulator types
All of the gates are transcriptional, where there are two input promoters (PIN1 and PIN2) and 
one output promoter (POUT). Two-input transcriptional logic gates have not yet been built 
for CRISPRi and RNA-IN/OUT so we hypothesize how these biochemistries could be used. 
The graphs at the right show how the gates will respond to inputs introduced at the same 
time (graphs at left) or sequentially (right). In all panels, the on state is assumed to generate 
ten fold higher than the off state. (a) A NOR gate is shown based on a repressor that binds 
DNA110. The lines are based on measured induction (τ1/2 ~36 min) and relaxation (τ1/2 ~35 
min) half-lives226. (b) An AND gate based on an activator that binds DNA that requires a 
second protein to be active55. The lines are based on a measured induction (τ1/2 ~36 min)55 
and approximate relaxation (τ1/2 ~35 min) half-life. (c) A NOR gate based on integrases that 
flip two terminators to turn off the output122,123. We assume a small readthrough 
probability, which leads to a change in the rate when only one terminator is flipped. 
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Conceptually, a NOR gate could also be constructed by having two input promoters in series 
drive the expression of a single integrase. The lines are based on an on-rate of 1.8 
hours119,121,122. (d) An AND gate based on integrases122. The same on- and off- rates are 
used as in part c. (e) A NOR gate could be built based on CRISPRi by setting a constitutive 
level of Cas9 expression and then having the two input promoters drive the expression of 
two guide RNAs. The lines are based on measured induction (τ1/2 = 35 min) and relaxation 
(τ1/2 = 47 min) half-lives79. (f) A NOR gate could be built based on the RNA-IN/RNA-OUT 
system developed by Arkin and co-workers80. RNA-OUT represses translation of tnaC, 
which allows Rho to bind the mRNA and repress transcription of the output. The CRISPR 
machinery needed to process RNA-IN mRNA for this circuit is not shown. The lines are 
based on theoretical induction (τ1/2 ~30 min) and relaxation (τ1/2 ~35 min) half-lives162,226.
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Figure 3. Methods of Modifying Circuit Behavior
ODE models were built to simulate a NOT gate and an oscillator. Model equations and 
parameters are included in the SI in SMBL format205,227. Parameters were adjusted to 
demonstrate the effect of each tuning knob on circuit behavior. Every panel displays circuit 
outputs with original parameter values (black) or tuning knob variations (grey). Inputs in (a-
f) are IPTG. (a/h) Architecture and ideal response functions for the NOT gate (a) and 
oscillator (h). (b/i) Promoter strength. In both circuits, promoter strength is increased 
(dashed grey line) or decreased (solid grey line) by a factor of two. (c/j) Enzymatic 
degradation of the reporter protein was modeled as a five fold increase in the protein 
degradation rate228. (d/k) Gene dosage. The circuits are moved between a high copy 
plasmids (dashed grey line) and the genome (solid grey line) to tune expression. The high 
copy plasmid is assumed to be ten times more abundant than the original circuit. (e/l) 
Ribosome binding site strength. Repressor RBSs (RBS1) are increased (dashed grey line) or 
decreased (solid grey line) by a factor of five. Altering the reporter RBS would shift the 
output of both circuits vertically (not pictured). (f/m) Small RNA designed to bind repressor 
mRNA are modeled with the introduction of a new species that binds repressor mRNA with 
the same affinity as a ribosome (this value was chosen arbitrarily and can be modulated to 
change circuit dynamics). In this model, small RNAs are produced constitutively and sRNA/
mRNA duplexes are degraded faster than either RNA alone. (g/n) Decoy operators that bind 
repressor proteins. Decoy operators were modeled by introducing a new species that binds 
repressor protein with the same Kd as the repressible promoter. The oscillator model has 25 
decoy operator sites, however circuits can be tuned with more or less as needed.
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Figure 4. Common failure modes and their impact on circuit dynamics. (a)
An AND gate71 and oscillator70 are used as model systems to demonstrate the assembly of 
parts to build more complex circuits. Repression is indicated with a blunt ended connector 
and activation is indicated with an arrow. For the AND gate, the input promoters are PIN1 
and PIN2 and the output promoter is PR3. Promoters are named by the repressor to which it 
responds (e.g., PR1 is repressed by R1). The steady-state response to different combinations 
of inputs is shown as a bar graph, where the OFF states are grey and the ON state is black. 
For the oscillator, the promoters PA-R are repressed by R and activated by A. The impact of 
various failures (red lines) are shown for the AND gate (left) and oscillator (right) with 
expected dynamics shown in black. Models were used to simulate the R2 NOT gate, the 
AND gate71, and oscillator. Parameters and model equations are included in the SI in SBML 
format205,227. Unless indicated otherwise, Input 2 is the input to the NOT gate transfer 
function. (b) Mismatched response functions. In the AND gate, R3 was modeled as a 
different repressor: Bet1 (kd = 0.2, n = 2.4, max = 13, min = 0.4) instead of Orf2 (kd = 0.4, n 
= 6.1, max = 16, min = 0.2)71. R2 is the input for the R3 transfer function. In the oscillator, 
the R translation rate is increased ten-fold. (c) Promoter context. Strength of the indicated 
promoters is reduced by 50% in both circuits. (d) RBS context. The translation rates of R2 
(AND gate) and R (oscillator) are set to zero. Input 1 is the input for the R2 transfer function 
(e) Transcriptional read-through. 30% read-through from upstream operons through the red 
terminator is simulated in both circuits. (f) Part-junction interference. A new constitutive 
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promoter (AND gate) is simulated as approximately 20% of the strength of PIN2. New 
terminator (oscillator) decreases transcription 40%. (g) Orthogonality. R3max is set as R2min 
to simulate repression of PR3 by R2. Additional equations are added to the oscillator model 
to simulate repressor-activator complex formation. (h) Recombination. R2 and R were 
removed from the AND gate and oscillator models, respectively.
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Figure 5. Circuit performance within the context of a living cell. (a)
Recombinant protein expression can cause a growth defect by reducing the availability of 
host resources (e.g., RNAP and ribosomes). Here, synthetic sRNAs compete with mRNA for 
ribosomes to illustrate the impact of exogenous protein expression on host resource 
allocation. When sRNAs are produced (left graph, grey bars), ribosomes are titrated away 
from fluorescent protein mRNA and observed fluorescence is reduced relative to no sRNA 
(left graph, white bars)151. Center graph, colored circles represent the overexpression of 
different proteins in E. coli (blue: Pu promoter β-Galactosidase, red: T7 promoter β-
Galactosidase, black: tac promoter ΔEF-Tu, green: bla promoter β-Lactamase)229. Right 
graph, colored circles represent growth of different bacterial strains as a function of rRNA 
supply (blue: E. coli 30°C, green: A. aerogenes 37°C, red: C. utilis 25°C, orange: C. utilis 
30°C, black: N. crassa 30°C)229. (b) Queuing as a result of overloading the ClpXP protease 
machinery with proteins from a synthetic oscillator. The graph shows the difference between 
expected (black) and measured (red) dynamics for an oscillator affected by queuing166. (c) 
Brophy and Voigt Page 28
Nat Methods. Author manuscript; available in PMC 2014 November 13.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
An additional output (PR2) on a high copy plasmid is added to the NOT gate. This causes 
retroactivity, which alters the activation dynamics of the original output (PR1) (black line: 
original dynamic response, orange line: retroactive effect)195. (d) One plasmid with two 
reporter proteins is transformed into different E. coli strains. The ratio of expression varies 
in some strains (left graph: wild type E. coli strains, right graph: KEIO collection 
knockouts)196. (e) Different media impact the performance of an AND gate based on T7 
RNAP2,102. Data are shown for the circuit in the absence (white) and presence (black) of 
both inputs in different medias (LB: luria broth, Min: minimal media, #T and/or #L: 
minimal media supplemented with tryptone (#T = #g/L) or yeast extract (#Y = #g/L).
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Figure 6. Conceptual circuit for a therapeutic bacterium that colonizes a niche in the human 
microbiome and delivers a drug
This circuit demonstrates how the different classes of regulators and circuits described in 
this review could be combined into a single system. The leftmost panel shows genetically 
modified bacteria that have colonized the interior of a human gastrointestinal tract. The 
upper right panel focuses on the conceptual circuit that the bacteria use to regulate their 
growth and deliver drugs to the human patient. An analog circuit103 (left) and irreversible 
recombinases (right) are highlighted in the insets to emphasize the diverse biochemistries 
used to build this circuit.
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